How does pathological skin involvement (i.e. nipple, epidermis) but not clinical skin involvement change your recommendations regarding PMRT in the absence of other risk factors?   

Does that change if they received a skin sparing mastectomy?



Answer from: Radiation Oncologist at Community Practice